Evaluating the Epidemiology and Determinants of Neurologic Post-acute Sequelae of SARS-CoV-2

Medicine and Dentistry

1. Acute Disease 5%
2. Antibodies 11%
3. Autoantibodies 11%
4. Autoimmunity 5%
5. Biorepository 5%
6. Biostatistics 5%
7. Clinician 5%
8. Cognitive Defect 5%
9. Cohort Analysis 5%
10. Cohort Effect 100%
11. COVID-19 17%
12. Diseases 5%
13. Dysautonomia 11%
14. Dysbiosis 11%
15. Immunity 17%
16. Immunology 5%
17. Infectious Disease 5%
18. Medicine 5%
19. Microbiome 17%
20. Neurologic Disease 5%
21. Pathophysiology 5%
22. Public Health 5%
23. Sequela 100%
24. Severe Acute Respiratory Syndrome Coronavirus 2 100%
25. Virus Nucleocapsid 5%